Lipocine
LPCNPhase 3IMPROVED DRUG ABSORPTION | BETTER PATIENT COMPLIANCE Improving Health We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine […]
Market Cap
$52.2M
+100.8% period
Pipeline
8
5 in Phase 3
Patents
—
Publications
—
LPCN · Stock Price
USD 7.15+3.59 (+100.84%)
Historical price data
About
IMPROVED DRUG ABSORPTION | BETTER PATIENT COMPLIANCE Improving Health We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine […]
Drug Delivery
Pipeline
88 drugs in pipeline5 in Phase 3
| Drug | Indication | Stage | Watch |
|---|---|---|---|
| LPCN 1021 | Hypogonadism, Male | Phase 3 | |
| LPCN 1021 | Hypogonadism, Male | Phase 3 | |
| Oral testosterone undecanoate, LPCN 1021 + Topical testoster... | Male Hypogonadism | Phase 3 | |
| LPCN 1021 | Hypogonadism, Male | Phase 3 | |
| LPCN 1154A + Placebo | Depression, Postpartum | Phase 3 |
Funding History
3Total raised:$60M
Debt$10MMar 15, 2022
PIPE$20MDec 15, 2020
IPO$30MJun 15, 2016